A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves' disease.

Autor: Chielens L; Department of Paediatrics, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium., Nauwynck E; Division of Paediatric Endocrinology, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium. elise.nauwynck@uzbrussel.be., Bourgeois S; Department of Nuclear Medicine, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium., Staels W; Division of Paediatric Endocrinology, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium.; Genetics, Reproduction and Development (GRAD), Beta Cell Neogenesis (BENE) Research Unit, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium., Vanbesien J; Division of Paediatric Endocrinology, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium., Gies I; Division of Paediatric Endocrinology, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium.; Growth and Development (GRON) Research Unit, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium., Ernst C; Department of Radiology, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium., Everaert H; Department of Nuclear Medicine, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium., De Schepper J; Division of Paediatric Endocrinology, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 110, Brussels, 1090, Belgium.; Growth and Development (GRON) Research Unit, Vrije Universiteit Brussel, Laarbeeklaan 103, Brussels, 1090, Belgium.

Publikováno v: Scientific reports [Sci Rep] 2024 Dec 28; Vol. 14 (1), pp. 31063. Date of Electronic Publication: 2024 Dec 28.